European Neurology
Complicated Migraine in AS HemoglobinopathyBussone G. · La Mantia L. · Boiardi A. · Parati E.A. · Frediani F. · Testa D.Istituto Neurologico C. Besta, Milano, Italia
Keywords: Complicated migraineAS hemoglobinopathy |
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: February 03, 1983
Accepted: August 11, 1983
Published online: January 31, 2008
Issue release date: 1984
Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 0
ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)
For additional information: https://www.karger.com/ENE
Abstract
Neurological manifestations have been rarely described in sickle cell trait carriers. Almost all the patients up to now reported are black and young of age. An adult white man is reported, with AS hemoglobinopathy, affected by complicated migraine, who developed acute occlusion of two middle cerebral artery branches, with persistent neurological deficit. The possible significance of this association is discussed.
© 1984 S. Karger AG, Basel
Related Articles:
Article / Publication Details
Received: February 03, 1983
Accepted: August 11, 1983
Published online: January 31, 2008
Issue release date: 1984
Number of Print Pages: 4
Number of Figures: 0
Number of Tables: 0
ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)
For additional information: https://www.karger.com/ENE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

Get Permission